MARC details
000 -LEADER |
fixed length control field |
02447nam a22003017a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
180508s20172017 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1758-3772 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.17925/EE.2017.13.01.26 [doi] |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
PMC5813442 [pmc] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
29632603 |
245 ## - TITLE STATEMENT |
Title |
Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive Iodine. |
251 ## - Source |
Source |
European Endocrinology. 13(1):26-29, 2017 Apr |
252 ## - Abbreviated Source |
Abbreviated source |
Eur Endocrinol. 13(1):26-29, 2017 Apr |
253 ## - Journal Name |
Journal name |
European endocrinology |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2017 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2018 |
266 ## - Date added to catalog |
Date added to catalog |
2018-05-08 |
520 ## - SUMMARY, ETC. |
Abstract |
<b>Background</b>: The Thyroid Cancer Care Collaborative developed a web-based clinical decision-making module (CDMM) to inform risk-adjusted decisions on post-thyroidectomy radioactive iodine (RAI) use in papillary thyroid cancer (PTC). <b>Methods</b>: In a pilot study, we evaluated the CDMM in 19 PTC cases representing low- (five), intermediate- (seven) and high-risk (seven) disease. Two PTC experts and 10 PTC physicians reviewed cases and assigned risk level and RAI recommendation. The experts used a standard approach while the others used the CDMM. We assessed agreement between responses using a weighted Kappa. <b>Results</b>: Between experts, risk-assignment was concordant in 100%, 57% and 86% of low-, intermediate- and high-risk cases, respectively. Between CDMM users, risk-assignment was concordant in 100%, 29% and 14% in low-, intermediate- and high-risk cases, respectively (p=0.01). CDMM-assigned risk agreed with the expert-assigned risk in 100%, 25% and 0% of low-, intermediate- and high-risk cases, respectively (Kappa=0.69). For RAI use, the experts agreed in 15 cases while CDMM users agreed in eight. On further analysis, interpretation of extrathyroidal extension and lymph node staging led to discrepancies with the CDMM. <b>Conclusions</b>: For a web-based CDMM to accurately inform appropriate use of RAI in PTC, standard pathological and surgical reports are necessary. |
546 ## - LANGUAGE NOTE |
Language note |
English |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Washington Hospital Centereonard |
656 ## - INDEX TERM--OCCUPATION |
Department |
Medicine/Endocrinology |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Wartofsky, Leonard |
790 ## - Authors |
All authors |
Baxi SS, Bickford C, Dewey E, Eaton A, Fish S, Kurtzman R, Michael Tuttle R, Wartofsky L |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.17925/EE.2017.13.01.26">https://dx.doi.org/10.17925/EE.2017.13.01.26</a> |
Public note |
https://dx.doi.org/10.17925/EE.2017.13.01.26 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |